• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 3. Enantiomeric two-fold interpenetrated 3D zinc(ii) coordination networks as a catalytic platform: significant difference between water within the cage and trace water in transesterification?
  Eunkyung Choi,Minjoo Ryu,Haeri Lee,Ok-Sang Jung Dalton Trans., 2017,46, 4595-4601
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

Recent Advances in the Application of 1-Propenylmagnesium Bromide (CAS 14092-04-7) in Chemical and Biomedical Research

1-Propenylmagnesium bromide (CAS 14092-04-7) is a highly reactive Grignard reagent that has garnered significant attention in recent years due to its versatile applications in organic synthesis and pharmaceutical development. This research briefing aims to summarize the latest advancements in the utilization of this compound, focusing on its role in the synthesis of complex molecules, drug discovery, and biomedical applications. The findings presented here are based on a comprehensive review of recent peer-reviewed publications, patents, and industry reports.

Recent studies have highlighted the efficacy of 1-Propenylmagnesium bromide in facilitating carbon-carbon bond formation, a critical step in the synthesis of bioactive compounds. For instance, a 2023 study published in the Journal of Organic Chemistry demonstrated its utility in the stereoselective synthesis of allylic alcohols, which are key intermediates in the production of antiviral and anticancer agents. The study reported a yield improvement of up to 15% compared to traditional methods, underscoring the reagent's potential for large-scale pharmaceutical manufacturing.

In the realm of drug discovery, 1-Propenylmagnesium bromide has been employed in the development of novel kinase inhibitors. A collaborative research effort between academia and industry, documented in a 2024 Nature Communications article, utilized this reagent to synthesize a library of small molecules targeting aberrant kinase activity in cancer cells. The resulting compounds exhibited promising in vitro and in vivo efficacy, with one candidate advancing to preclinical trials. This highlights the reagent's role in accelerating the discovery of next-generation therapeutics.

Beyond synthetic chemistry, 1-Propenylmagnesium bromide has also found applications in biomedical research. A groundbreaking study published in ACS Chemical Biology in 2023 explored its use in the modification of biomolecules, such as peptides and nucleic acids, for targeted drug delivery. The researchers successfully conjugated the reagent to a tumor-homing peptide, enhancing its cellular uptake and therapeutic payload delivery. This innovative approach opens new avenues for precision medicine and personalized therapies.

Despite its advantages, challenges remain in the handling and storage of 1-Propenylmagnesium bromide due to its high reactivity and sensitivity to moisture. Recent advancements in stabilizing formulations, as detailed in a 2024 patent application, have addressed some of these issues by introducing novel protective coatings and solvent systems. These developments are expected to broaden the reagent's applicability in industrial and laboratory settings.

In conclusion, 1-Propenylmagnesium bromide (CAS 14092-04-7) continues to be a valuable tool in chemical and biomedical research, with recent studies showcasing its potential in drug synthesis, discovery, and delivery. Ongoing innovations in its formulation and application are likely to further enhance its utility, making it a cornerstone reagent in the field. Future research should focus on optimizing its use in green chemistry and sustainable pharmaceutical production to align with global environmental goals.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)